A randomised study comparing the antiplatelet and antiinflammatory effect of clopidogrel 150 mg/day versus 75 mg/day in patients with ST-segment elevation acute myocardial infarction and poor responsiveness to clopidogrel: results from the DOUBLE study - Palmerini, T; Barozzi, C; Tomasi, L (Thrombosis Research, 2010)
et al.